ACAD
37.04
+0.3
+0.82%
AEMD
6.23
-0.06
-0.95%
APRI
0.309
-0.012
-3.8641%
ARNA
1.67
-0.01
-0.60%
ATEC
0.41
+0.03
+7.92%
CNAT
2.26
-0.03
-1.31%
CRXM
0.177
-0.003
-1.667%
CYTX
2.17
+0.12
+5.85%
DXCM
92.23
+2.67
+2.98%
GNMK
10.65
+0.39
+3.80%
HALO
9.94
+0.17
+1.74%
ILMN
166.35
-0.07
-0.04%
INNV
0.54
-0.01
-1.80%
INO
9.88
+0.26
+2.70%
ISCO
1.99
0.00
0.00%
ISIS
57.56
0.00
0.00%
LGND
134.88
-0.01
-0.01%
LPTN
1.95
-0.05
-2.50%
MBVX
0.6
-0.05
-7.69%
MEIP
1.36
0.00
-0.01%
MNOV
6.2
+0.13
+2.14%
MRTX
4.64
+0.08
+1.75%
MSTX
0.357
-0.006
-1.6249%
NBIX
50.23
+0.08
+0.16%
NUVA
62.2
+0.18
+0.29%
ONCS
1.82
+0.03
+1.68%
ONVO
4.28
-0.01
-0.23%
OREX
3.35
-0.03
-0.89%
OTIC
14.36
-0.1
-0.69%
QDEL
22.8
-0.44
-1.89%
RCPT
231.96
0.00
0.00%
RGLS
3.57
0.00
+0.14%
RMD
68.88
+3.18
+4.84%
SPHS
5.86
+0.46
+8.52%
SRNE
6.29
+0.1
+1.62%
TROV
5.63
+0.18
+3.30%
VICL
4.15
-0.05
-1.19%
VOLC
18
0.00
0.00%
ZGNX
9.13
+0.05
+0.55%
ACAD
37.04
+0.3
+0.82%
AEMD
6.23
-0.06
-0.95%
APRI
0.309
-0.012
-3.8641%
ARNA
1.67
-0.01
-0.60%
ATEC
0.41
+0.03
+7.92%
CNAT
2.26
-0.03
-1.31%
CRXM
0.177
-0.003
-1.667%
CYTX
2.17
+0.12
+5.85%
DXCM
92.23
+2.67
+2.98%
GNMK
10.65
+0.39
+3.80%
HALO
9.94
+0.17
+1.74%
ILMN
166.35
-0.07
-0.04%
INNV
0.54
-0.01
-1.80%
INO
9.88
+0.26
+2.70%
ISCO
1.99
0.00
0.00%
ISIS
57.56
0.00
0.00%
LGND
134.88
-0.01
-0.01%
LPTN
1.95
-0.05
-2.50%
MBVX
0.6
-0.05
-7.69%
MEIP
1.36
0.00
-0.01%
MNOV
6.2
+0.13
+2.14%
MRTX
4.64
+0.08
+1.75%
MSTX
0.357
-0.006
-1.6249%
NBIX
50.23
+0.08
+0.16%
NUVA
62.2
+0.18
+0.29%
ONCS
1.82
+0.03
+1.68%
ONVO
4.28
-0.01
-0.23%
OREX
3.35
-0.03
-0.89%
OTIC
14.36
-0.1
-0.69%
QDEL
22.8
-0.44
-1.89%
RCPT
231.96
0.00
0.00%
RGLS
3.57
0.00
+0.14%
RMD
68.88
+3.18
+4.84%
SPHS
5.86
+0.46
+8.52%
SRNE
6.29
+0.1
+1.62%
TROV
5.63
+0.18
+3.30%
VICL
4.15
-0.05
-1.19%
VOLC
18
0.00
0.00%
ZGNX
9.13
+0.05
+0.55%
Home » Bio: Brian Orelli

Bio: Brian Orelli

Somewhere between his graduate thesis at the University of Chicago on BRCA1 and his postdoctoral fellowship in DNA repair at the Ludwig Institute, Brian realized he enjoyed analyzing other people’s data more than running his own experiments. And thus a career in science writing was born. Brian provides freelance articles for The Motley Fool, BioWorld, Nature Biotechnology, and anyone else that will let him write at the intersection of drugs and business.